Lydia Usha

Cancer Risks Associated With Germline<i>PALB2</i>Pathogenic Variants: An International Study of 524 Families

Xin Yang, Goska Leslie, Alicja Doroszuk et al. · Journal of Clinical Oncology · 2019 · 418 citations · Full text

Life Sciences, Genetics, Oncology +17

Safety and Efficacy of Palbociclib and Radiation Therapy in Patients With Metastatic Breast Cancer: Initial Results of a Novel Combination

Mudit Chowdhary, Neilayan Sen, Akansha Chowdhary et al. · Advances in Radiation Oncology · 2019 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies

Lydia Usha, Michael W. Sill, Kathleen M. Darcy et al. · Gynecologic Oncology · 2011 · 50 citations

Medicine, Gynecology, Oncology +17

Inhibition of p70 S6 Kinase (S6K1) Activity by A77 1726 and Its Effect on Cell Proliferation and Cell Cycle Progress

Michelle E. Doscas, Ashley J. Williamson, Lydia Usha et al. · Neoplasia · 2014 · 33 citations · Full text

Medicine, Molecular Biology, Pharmacology +13

Effects of <i>ERBB2</i> amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer

Larry E. Morrison, Susan Jewell, Lydia Usha et al. · Genes Chromosomes and Cancer · 2007 · 26 citations

Medicine, Genetics, Oncology +17